InvestorsHub Logo

adam8700

07/26/12 2:49 PM

#4649 RE: markkind #4648

I am thinking the same thing.

MasterMerlins

07/27/12 2:54 AM

#4650 RE: markkind #4648

If your asking my Opinion.. I would say I would have preferred them to do so..!

Now.. There are certain things that we as ShareHolders do not think about..

For Example.. The Human Side of the Equation.. I was reading an article Yesterday, about Doxil and the PROBLEMS that the Ben Venue Facility Shutdown caused..! There are PEOPLE that Depend on some of these Drugs..!

Actually, I will share it..

http://www.cnn.com/2012/07/25/health/fda-drug-shortages/index.html

Kind of an Eye Opener.. At least to me.. Some of the things we focus on when it comes to drugs .. Sometimes are Trivial..!

Now.. Let's take Totect .. And how this Shortage might or might have not affected any people out there.. I know that it does not SERVE the same purpose as Doxil.. But, were you able to see pictures of people that have had Anthracycline Extravasation..?
They lose part of their Body..!

And Totect is the ONLY drug that can be used for that type of situation.. There is NO GENERIC..!

Anyways.. I am not even sure if the Re-Launch is OFFICIAL..! I guess we will find out in about 3 Weeks ( If we don't get a P.R. before that ).. We should have the 2Q Conference Call around mid August.. Unless.. Somebody calls I.R. and asks them..

But, to be honest.. As a Shareholder.. I am Glad the Products are ALREADY at the Market.. Patients Benefit and we should benefit as Well..!

Lostcoastkid

07/28/12 4:15 PM

#4665 RE: markkind #4648

Some update for you.....


Markkind .....sorry I don't have private messaging now, but the latest on GTG$..... In today's Montana newspaper......it could get really interesting, hope your still holding

http://mtstandard.com/news/local/mse-oks-sale-contract/article_a365210a-d86a-11e1-a6a7-001a4bcf887a.html